Yongkang K. Gai

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 119 publications

68Ga-Labeled LLP2A for PET Imaging of Very Late Antigen-4 in Acute Cardiac Rejection.

68Ga-Labeled LLP2A for PET Imaging of Very Late Antigen-4 in Acute Cardiac Rejection.

Journal: Molecular pharmaceutics
Published: June 03, 2026

Immuno-PET imaging of mesothelin in ovarian cancer with 68Ga-XH04: a first-in-human study.

Immuno-PET imaging of mesothelin in ovarian cancer with 68Ga-XH04: a first-in-human study.

Journal: Biomarker research
Published: May 21, 2026

Decoupling Alzheimer Disease Pathologic Abnormalities at PET with Improved Clinical Relevance by Interpretable Adversarial Decomposition Learning.

Decoupling Alzheimer Disease Pathologic Abnormalities at PET with Improved Clinical Relevance by Interpretable Adversarial Decomposition Learning.

Journal: Radiology
Published: April 07, 2026

PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

PARP Inhibitors plus Anlotinib as Bridging Therapy for Armored CAR-T Cells in Ovarian Cancer Enhances Infiltration and Antitumor Efficacy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 25, 2026

In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer's disease continuum.

In vivo multimodal PET/MRI imaging and plasma biomarkers implicate glymphatic dysfunction linking neuroinflammation to tau pathology in the early Alzheimer's disease continuum.

Journal: European journal of nuclear medicine and molecular imaging
Published: February 26, 2026

Differences comparison in asymmetry index from OSEM and BPL reconstructed 18F-FDG PET-MRI in temporal lobe epilepsy focus localization

Differences comparison in asymmetry index from OSEM and BPL reconstructed 18F-FDG PET-MRI in temporal lobe epilepsy focus localization

Journal: Zhonghua yi xue za zhi
Published: January 26, 2026

Immuno-PET Imaging of Tumor Mesothelin Expression with a Gallium-68 Radiolabeled Nanobody.

Immuno-PET Imaging of Tumor Mesothelin Expression with a Gallium-68 Radiolabeled Nanobody.

Journal: Molecular pharmaceutics
Published: January 12, 2026

Cascaded deep learning enables multimodal brain PET spatial normalization and quantification for Alzheimer's disease.

Cascaded deep learning enables multimodal brain PET spatial normalization and quantification for Alzheimer's disease.

Journal: NeuroImage
Published: December 20, 2025

The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015-2025).

The CXCR4-targeted theranostics era: a comprehensive review of a decade of progress (2015-2025).

Journal: Theranostics
Published: December 19, 2025

S1PR-Targeted PET Imaging: Advancing Insights into Neuroinflammatory and Immune-Related Pathologies.

S1PR-Targeted PET Imaging: Advancing Insights into Neuroinflammatory and Immune-Related Pathologies.

Journal: Molecular pharmaceutics
Published: December 15, 2025

Integrated 68Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort.

Integrated 68Ga-PSMA PET/MRI models improve prostate cancer diagnosis and ISUP stratification, especially in the low-PSA cohort.

Journal: EJNMMI research
Published: November 22, 2025

Enhancing Triple-Negative Breast Cancer Radiotherapy via EZH2-Targeted Nanoplatform and Radionuclide Therapy.

Enhancing Triple-Negative Breast Cancer Radiotherapy via EZH2-Targeted Nanoplatform and Radionuclide Therapy.

Journal: Molecular pharmaceutics
Published: November 22, 2025
Showing 1-12 of 119

Last Updated: 09/26/2026